ozanimod
Selected indexed studies
- Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis. (N Engl J Med, 2021) [PMID:34587385]
- Ozanimod: First Approval. (Drugs, 2020) [PMID:32385738]
- Ozanimod. (, 2012) [PMID:34383397]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Update on ozanimod for ulcerative colitis. (2022) pubmed
- Ozanimod: A Review in Relapsing Forms of Multiple Sclerosis. (2024) pubmed
- Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis. (2021) pubmed
- Ozanimod: First Approval. (2020) pubmed
- Ozanimod. (2012) pubmed
- Ozanimod: A Review in Ulcerative Colitis. (2022) pubmed
- Ozanimod. (2006) pubmed
- Ozanimod (Zeposia) for multiple sclerosis. (2020) pubmed
- PMID:40773579 (2021) pubmed
- Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies. (2024) pubmed